As part of our official DealFlow Discovery Conference Interview Series, produced by Mission Matters, along with our partner DealFlow Events, we’re showcasing the innovative companies presenting at the upcoming DealFlow Discovery Conference (January 28-29, at the Borgata in Atlantic City) and the executives behind them.

In this episode, Adam Torres interviews Anil Diwan, Founder of NanoViricides Inc., about the company’s mission to develop revolutionary antiviral therapies. Anil explains the vision for empiric antiviral treatment, the challenges of viral mutation, and how NanoViricides is advancing its approach through the NV-387 program.

This interview is part of our effort to help investors discover compelling companies ahead of the event — and to help CEOs introduce their story to the 1500+ conference attendees.

Learn more about the event and presenting companies:
https://dealflowdiscoveryconference.com/

About Anil Diwan

Dr. Diwan has been President and Chairman of the Board of the Company since its founding in 2005 Dr. Diwan spearheaded the efforts for the Company's 2013 uplisting from the OTC Markets to NYSE-American. Dr. Diwan has led several of the Company's financing efforts since 2010.

About NanoViricides Inc.

NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in class drugs against viruses.

A nanoviricide is designed to specifically attack enveloped virus particles, on the same sites that they use to bind to cells, and dismantle them, blocking reinfection cycle, going beyond what antibodies and immunotherapeutics do. A nanoviricide can also be designed to deliver anti-viral payload into infected cells sparing uninfected cells to block replication cycle without toxicity. Our unique biomimetic approach enables creation of drugs that a virus would be highly unlikely to escape due to mutations.

Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.

Apply to be a guest on our podcast:

https://missionmatters.lpages.co/podcastguest/

Visit our website:

https://missionmatters.com/

More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Weekend Round Up: NB GP, Cardiff BMC, & More